Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2010
06/10/2010WO2010021681A3 Compositions and methods for treatment of viral diseases
06/10/2010WO2010018109A3 Substituted aminotetralines
06/10/2010WO2010013835A3 Solid pharmaceutical composition
06/10/2010WO2010011349A3 Pyrimidine-2,4-diamines as jak2 kinase inhibitors for treatment of inflammation
06/10/2010WO2010002956A3 Heterocyclic derivatives as modulators of ion channels
06/10/2010WO2010002804A3 Method and compositions for inhibition of double stranded dna viruses
06/10/2010WO2009157018A9 Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof
06/10/2010WO2009156041A3 Thiazolyl piperdine derivatives
06/10/2010WO2009147170A3 Drug combinations comprising a dgat inhibitor and a ppar-agonist
06/10/2010WO2009108829A3 Crystal forms of 2-{2-[(cyclohexyl)methylene]hydrazino}adenosine
06/10/2010WO2009104051A3 Combinational therapeutics for treatment of prostate cancer using epoxy encapsulated magnetic particles and rnai medicine
06/10/2010WO2009095588A3 Synthesis of novel neamine derivatives and use thereof as antibacterial agents
06/10/2010WO2009073186A8 Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling
06/10/2010WO2009060282A3 Stilbene derivatives as pstat3/il-6 inhibitors
06/10/2010WO2009058267A3 Benzomorpholine derivatives and methods of use
06/10/2010WO2009033561A8 Substituted 6-phenylnicotinic acids and the use thereof
06/10/2010WO2008144500A3 1-methyl-benzo[1,2,4]thiadiazine, 1-oxide derivatives
06/10/2010US20100146648 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction)
06/10/2010US20100145441 Therapeutic agents for angiogenesis-related diseases comprising chondromodulin-i as active ingredient
06/10/2010US20100145255 System And Method For Reducing The Appearance Of Fine Lines And Wrinkles And Improving the Skin Tone
06/10/2010US20100145252 Prevention of indwelling device related infection: compositions and methods
06/10/2010US20100145251 Prevention of indwelling device related infection: compositions and methods
06/10/2010US20100145180 Apparatus for physical measurements of the eye
06/10/2010US20100145071 Small molecule inhibitors of rotamase enzyme activity
06/10/2010US20100145058 Barium salt of benzimidazole derivative
06/10/2010US20100145056 Acetyl 2-hydroxy-1,3-diaminoalkanes
06/10/2010US20100145048 Compounds for the treatment of inflammatory disorders
06/10/2010US20100144903 Methods of diagnosis and treatment of crohn's disease
06/10/2010US20100144892 Method of producing organic certified glycerin
06/10/2010US20100144891 Use of cyclohexanehexol derivatives in the treatment of amyotrophic lateral sclerosis
06/10/2010US20100144890 Use of a surfactant for the preparation of a formulation for the treatment of adipose diseases
06/10/2010US20100144889 Cholesterol control agent
06/10/2010US20100144887 Crystalline solid rasagiline base
06/10/2010US20100144886 Method for treating pulmonary arterial hypertension
06/10/2010US20100144885 Histone acetyl transferase activators and histone deacetylase inhibitors in the treatment of alcoholism
06/10/2010US20100144884 Novel 3-phenyl acrylic acid compound activators of type ppar receptors and pharmaceutical/cosmetic compositions comprised thereof
06/10/2010US20100144883 Topically applicable compositions for the treatment of keratinization disorders
06/10/2010US20100144882 treating acute post-bunionectomy pain with diclofenac potassium
06/10/2010US20100144881 Crystalline forms of a 3-carboxypropyl-aminotetralin compound
06/10/2010US20100144880 Amino acid inhibitors of plasmin
06/10/2010US20100144879 Antibiotic Compound
06/10/2010US20100144878 Nutritional supplement or functional food comprising oil combination
06/10/2010US20100144876 Modulator
06/10/2010US20100144875 Compositions and Methods for Preserving Brain Function
06/10/2010US20100144874 Use of a PPARalpha Agonist and Metformin for Decreasing the Serum Triglycerides
06/10/2010US20100144873 Treatment of myocarditis using fts
06/10/2010US20100144872 New Methylenebisphenyl Compounds Useful in the Treatment of Inflammation
06/10/2010US20100144871 Treating muscle wasting with selective androgen receptor modulators
06/10/2010US20100144869 Conjugates Comprising a gaba-or glycine compound, pharmaceutical compositions and combinations thereof as well as their use in treating cns disorders
06/10/2010US20100144868 Novel Neuroprotective Compounds and Uses Thereof
06/10/2010US20100144867 Use of lecithin:retinol acyl transferase gene promoter methylation in evaluating the cancer state of subject
06/10/2010US20100144866 Anti-fatigue agents and oral compositions containing andrographolide as active ingredient
06/10/2010US20100144865 Compound feed for aquaculture
06/10/2010US20100144864 Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders
06/10/2010US20100144863 Compounds and methods for treating autism spectrum disorders
06/10/2010US20100144862 Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
06/10/2010US20100144861 Perfluorocarbon gel formulations
06/10/2010US20100144860 Transglutaminase Inhibitor Comprising EGCG And A Method For Producing Thereof
06/10/2010US20100144859 Dimeric avermectin and milbemycin derivatives
06/10/2010US20100144858 Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator
06/10/2010US20100144857 Prenylflavanone compounds and uses thereof
06/10/2010US20100144856 Prenylfavanone compounds and uses thereof
06/10/2010US20100144855 APPLICATION OF SEDOISOPROSAN FOR PREPARATION OF MEDICINE FOR TREATMENT OF HUMAN HBeAg POSITIVE CHRONIC HEPATITIS B
06/10/2010US20100144854 Use of rhodamine 6g as a medicinal agent for treating malignant neoplasms and amiloidoses
06/10/2010US20100144853 Novel combined administration
06/10/2010US20100144852 Bicyclo[2.2.1]hept-7-ylamine Derivatives and Their Uses
06/10/2010US20100144851 RNA Interference Mediated Inhibition of Platelet-Derived Endothelial Cell Growth Factor (ECGF1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
06/10/2010US20100144849 METHOD FOR INHIBITING SIGNALING MEDIATED BY ErbB2, SIGNALING INHIBITOR TO BE USED THEREFOR AND USE THEREOF
06/10/2010US20100144848 Dna controlled assembly of lipid membranes
06/10/2010US20100144847 Fusion polypeptide suitable as a cytotoxin
06/10/2010US20100144846 Oligoribonucleotides and uses thereof
06/10/2010US20100144845 Oligonucleotide systems for targeted intracellular delivery
06/10/2010US20100144844 RNAi-MEDIATED INHIBITION OF H1F1A FOR TREATMENT OF OCULAR ANGIOGENESIS
06/10/2010US20100144843 Rnai therapeutic for respiratory virus infection
06/10/2010US20100144842 RNA Interference Mediated Inhibition of NOGO and NOGO Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA)
06/10/2010US20100144841 Control of nk cell function and survival by modulation of ship activity
06/10/2010US20100144840 Methods for Modulating the Efficacy of Nucleic Acid Based Therapies
06/10/2010US20100144839 Anti-cancer oligodeoxynucleotides
06/10/2010US20100144838 Methods for Identifying Modulators of Pyrimidine Tract Binding Protein
06/10/2010US20100144837 Diagnosis and treatment of malignant neoplasms
06/10/2010US20100144836 Methods for Detecting Epigenetic Modifications
06/10/2010US20100144835 Inhibition of gpr4
06/10/2010US20100144834 Methods for treating hypercholesterolemia
06/10/2010US20100144833 RNA interference; respiratory syncytial virus (RSV), parainfluenza virus (PIV); down-regulation of a gene(s) of a respiratory virus by oligonucleotides via RNA interference which are administered locally to the lungs and nasal passage via inhalation/intranasally or systemically via injection/intravenous
06/10/2010US20100144832 Prostate Cancer-Specific Alternations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations
06/10/2010US20100144831 Blocking of gene expression in eukaryotic cells
06/10/2010US20100144830 Cancer cell identification marker and cancer cell proliferation inhibitor
06/10/2010US20100144829 Novel Receptor Antagonists and Their Methods of Use
06/10/2010US20100144828 Caffeoylquinic acid derivatives containing nitrogen, and preparation method, pharmaceutical composition and usage thereof
06/10/2010US20100144827 Novel conjugates of polyunsaturated fatty acids with amines and therapeutic uses thereof
06/10/2010US20100144826 Salinosporamides and Methods for Use Thereof
06/10/2010US20100144825 Renin Inhibitors
06/10/2010US20100144824 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
06/10/2010US20100144823 Novel indole derivatives as selective androgen receptor modulators (sarms)
06/10/2010US20100144822 Use of Inhibitors of the Degradation of P27, in Particular Argyrin and Derivatives Thereof, for the Treatment of Proliferative Diseases
06/10/2010US20100144821 Compounds and methods for treating protein folding disorders
06/10/2010US20100144820 Therapeutic hpph dosage for pdt
06/10/2010US20100144818 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof
06/10/2010US20100144816 Functionally selective alpha2c adrenoreceptor agonists
06/10/2010US20100144815 Amino acid composition
1 ... 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 ... 7860